Menu

Pharmaceutical Litigation

855-797-9899

Pharmaceutical Litigation

Complications
after taking
Xarelto®?

Find out if you qualify
for legal recourse through
a FREE, private and no
obligation
case review by our Pharma Suits
patient advocates.

Free Case Review




Gastrointestinal Problems Tied to Xarelto

Home Xarelto Gastrointestinal Problems

Anti-coagulant (blood-thinning) medication Xarelto has been prescribed to 13 million patients for various health conditions. Its purpose is to reduce the risk of stroke in patients with atrial fibrillation (irregular heartbeat), to prevent blood clots after knee or hip replacement surgery, and to treat and prevent deep vein thrombosis (blood clots in the legs or pelvic region) and pulmonary embolism (blood clots in the lungs). Although it is meant to reduce health risks, Xarelto has a number of severe side effects, including serious gastrointestinal problems.

“Gastrointestinal” means of or affecting the stomach or intestines. WebMD lists Xarelto side effects including: indigestion; upper abdominal pain; and bleeding in the abdomen. Drugs.com lists Xarelto gastrointestinal symptoms including: bloody stools; bowel dysfunction; coughing up blood; black or red, tarry stools; vomiting blood or materials resembling coffee grounds; pain or swelling in the stomach or abdomen; clay-colored stools; diarrhea; and nausea or vomiting.

Recent research has shown an increased risk of serious gastrointestinal bleeding with Xarelto, as compared to warfarin, another anti-coagulant drug. The Xarelto website warns patients to get medical help right away if they have bright red or black stools, cough up blood or blood clots, or vomit blood or vomit that looks like coffee grounds.

It is important to speak with a knowledgeable pharmaceutical litigation attorney right away if you or your loved one has suffered gastrointestinal problems or any other of the severe side effects of Xarelto. You may be entitled to file a claim for compensation against the manufacturers of Xarelto, Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc.

At Farah & Farah, our practice is ready to help individuals who have been injured by dangerous drugs and devices. We are currently investigating Xarelto cases nationwide. You can have confidence that your case is in good hands with our firm.

Xarelto and Gastrointestinal Bleeding

The Mayo Clinic describes gastrointestinal bleeding as a symptom of a digestive tract disorder. This type of bleeding can range in severity from mild to serious and life-threatening. Bleeding in the digestive tract may show up as blood in the stools or vomit, and may cause to stools to appear black or tarry.

With severe gastrointestinal bleeding, patients can experience hypovolemic shock, an emergency condition in which the heart is unable to pump enough blood to the body because of severe blood and fluid loss. Organs of the body may stop working during hypovolemic shock, and the condition can be fatal.

Research Linking Xarelto and Gastrointestinal Bleeding

A study on the risk of gastrointestinal bleeding with oral anti-coagulants, comparing rivaroxaban (Xarelto) with warfarin, was published by the British Medical Journal (BMJ) in April 2015. The setting for the study was a large database of commercially insured patients in the U.S. between October 2010 and March 2012. Researchers in this study found a two-fold higher risk of gastrointestinal bleeding with rivaroxaban (Xarelto) than with warfarin.

RxList reports a number of clinical trials of Xarelto, including a study known as the ROCKET AF trial. In this study, 7,111 patients were given 15 to 20 mg of Xarelto orally, once daily, for a mean of 19 months to reduce the risk of stroke and blood clots, as compared to 7,125 patients on warfarin. There were 221 gastrointestinal bleeding events in the Xarelto group, as compared to 140 in the warfarin group.

The double-blind EINSTEIN Extension study, also reported on RxList, involved 598 subjects in the Xarelto group and 590 patients in the placebo group. Subjects were given 20 mg Xarelto orally once daily, or a placebo. The Xarelto group had 3 gastrointestinal bleeding events, while the placebo group had none.

Xarelto Gastrointestinal Problem Lawyers Investigating Cases Nationwide

At Farah & Farah, pharmaceutical and dangerous device litigation is what we do. Our knowledgeable Xarelto lawyers are committed to holding drug companies accountable and helping clients recover the compensation they need – and deserve. When you work with our firm in a Xarelto claim, you can have confidence that we will tenaciously pursue the maximum compensation you are entitled to receive.

If you have been injured by Xarelto, the sooner you speak with a Xarelto gastrointestinal problem attorney, the better. Evidence needs to be collected and preserved in your case. There are time limits imposed by law on dangerous drug injury claims. We offer a comprehensive case consultation, free of charge, with no obligation. Call us at (800) 533-3555 to find out if you have a Xarelto case and what damages you may be entitled to claim.


 

Need help now? Speak with a
Patient Advocate now:
855-797-9899

Who We Are

The pharmaceutical litigation attorneys at Farah & Farah go after negligent corporations that put unsuspecting consumers in harm's way. Pharmaceutical companies not only have a duty to manufacture drugs that are safe, but they also have the obligation to warn consumers regarding dangerous side effects that can be caused by these drugs.

Learn More